GI Insights

Host: Jay Goldstein, MD Guest: Douglas Drossman, MD Host Dr. Jay Goldstein discusses the latest in IBS & Functional GI Disorders (FGIDs) with guest expert Dr. Douglas Drossman of the Drossman Center for the Education and Practice of Integrated Care. Dr. Drossman is Professor Emeritus in the departments of Gastroenterology and Psychiatry at the Center for Functional GI and Motility, University...

Host Dr. Jay Goldstein welcomes Dr. Sunanda V. Kane, Professor of Medicine in the Department of Gastroenterology & Hepatology at Mayo Clinic, to dicuss the latest in Crohn's disease diagnosis and management. Dr. Kane is author o f IBD Self-Management: The AGA Guide to Crohn's Disease and Ulcerative Colitis, now in its second edition.

Host: Jay Goldstein, MD Guest: Stanley Cohen, MD What types of small bowel abnormalities are most common among pediatric patients? How can physicians investigate suspected small bowel disease or gastrointestinal (GI) bleeding in our younger patients? Dr. Stanley Cohen, gastroenterologist at the Combined Center for Inflammatory Bowel Disease and Children's Center for Digestive Health Care at Childr...

Host: Jay Goldstein, MD Guest: Jonathan Leighton, MD Guest: Moshe Rubin, MD Obscure gastrointesinal bleeding can pose investigational challenges. What are the potential causes of obscure GI bleeding? After initial negative upper endoscopy and colonoscopy tests are performed, what new technologies can help physicians more effectively detect small bowel abnormalities? Dr. Jonathan Leighton, professo...

Host: Lee Freedman, MD Guest: Brian Lacy, MD, PhD Resistance to proton pump inhibitors, or PPIs, is not uncommon among patients with gastroesophogeal reflux disease, or GERD. How should physicians initially approach managing patients with suspected GERD, and at what point should physicians classify a patient as a PPI non-responder? Our guest, Dr. Brian Lacy, associate professor of medicine at Dart...

Host: Jay Goldstein, MD Guest: Joel Brill, MD How do we categorize and define value-based purchasing, and how can it help us avoid unnecessary costs and foster better quality of care? What are some examples, and how do guidelines work in conjunction with value-based purchasing? Dr. Joel Brill, assistant clinical professor of medicine at the University of Arizona School of Medicine and chief medica...

Host: Jay Goldstein, MD Guest: Maria T. Abreu, MD Dr. Maria Abreu, professor of medicine and chief of the division of gastroenterology at the University of Miami Miller School of Medicine, joins host Dr. Jay Goldstein to discuss inflammatory bowel disease, or IBD, and women's reproductive health. Does inflammatory bowel disease, or IBD, affect female fertility? What influence does IBD have on the...

Host: Mark DeLegge, MD Guest: Rebecca West, JD The cost of malpractice insurance and the cost of resolving malpractice claims continues to climb. What are the trends in premiums for gastroenterologists around the country? And what are some of the most common risks and most commonly alleged errors? What’s the likelihood of a gastroenterologist being sued during his career? Rebecca West, CEO of Pied...

Host: Mark DeLegge, MD Guest: Jack Grider, PhD What is the underlying mechanism of propulsion in the digestive system, and how is motility stimulated? How are some newer pharmacotherapies looking to target serotonin to treat conditions such as IBS and constipation? Dr. Jack Grider, professor in the department of medicine, division of gastroenterology at the Virginia Commonwealth University School...

Host: Mark DeLegge, MD Guest: Miriam Vos, MD, MSPH Although it's important to consider the many factors that contribute to childhood obesity when designing a weight loss plan, sugar may be one of the most important components to target. Specifically, how does fructose influence childhood obesity? Dr. Miriam Vos, assistant professor in the department of gastroenterology at Emory University and auth...

Host: Jay Goldstein, MD Guest: Mansour Mohamadzadeh, PhD Researchers have developed an oral vaccine utilizing probiotics and, in preclinical studies, have found it successful in providing immunity against anthrax. Why are probiotics a good delivery component, and why might this method encourage a greater degree of response than the traditional vaccine injection? Dr. Mansour Mohamadzadeh, associate...

Host: Jay Goldstein, MD Guest: Elizabeth Montgomery, MD Gastroenterologists and pathologists often rely on each other to care for patients. How can clinicians and pathologists best facilitate each other's work for the good of the patient? Dr. Elizabeth Montgomery, professor of pathology and oncology at Johns Hopkins University School of Medicine, explores the interaction between gastroenterologist...

Host: Jay Goldstein, MD Guest: Linda Lee, MD How does delayed gastric emptying, or gastroparesis, affect patients? What are some of the common comorbid conditions of gastroparesis, and why are women and diabetic patients more susceptible? Dr. Linda Lee, clinical director of the division of gastroenterology and hepatology and director of the Johns Hopkins Integrative Medicine and Digestive Center a...

Host: Mark DeLegge, MD Guest: William Chey, MD Guest: Mark Pimentel, MD Irritable bowel syndrome, or IBS, affects a significant number of patients and can be challenging to treat. How might antibiotic therapy benefit IBS patients, and how is antibiotic therapy a unique option for treating IBS? Should physicians empirically treat IBS patients with antibiotics? Joining us to debate these questions a...

Host: Mark DeLegge, MD Guest: Charles Bernstein, MD Probiotics are becoming increasingly popular, but is there any substantial evidence supporting the efficacy of probiotics for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD)? Are there any potential risks to IBS and IBD patients using probiotic therapy? Which probiotic strains might be most beneficial, and what dosage is optim...

Host: Mark DeLegge, MD Guest: Alphonso Brown, MD, MS The causes of pancreatitis are often unknown, but we're learning that there are more potential causes than previously believed. Genetic causes are rare, but their detection has improved with new technology. What role might genetic testing play in correctly diagnosing and managing the condition? And what are the ramifications of genetic testing f...

Host: Jay Goldstein, MD Guest: Mark DeLegge, MD What unique perspectives can gastroenterologists offer to help manage and treat obesity, and how can gastroenterologists address the needs of their obese or overweight patients? When should a surgical bypass or lap-band procedure be considered? Host Dr. Jay Goldstein welcomes his GI Insights co-host, Dr. Mark DeLegge, to discuss the role of the gastr...

Host: Jay Goldstein, MD Guest: Deborah Proctor, MD Host Dr. Jay Goldstein welcomes Dr. Deborah Proctor, professor of medicine in the section of digestive diseases and medical director of the Inflammatory Bowel Disease Program at Yale University School of Medicine, to provide an overview of common female gastroenterological disorders. They discuss which gastroenterological disorders present differe...

Host: Jay Goldstein, MD Guest: Christian Stone, MD, MPH Incidents of Clostridium difficile, or C.diff , are increasing in the US. Are patients with ulcerative colitis or Crohn's disease more at risk for developing C. difficile infection than other patients? Is this due to an increased use of antibiotics in hospitals, or are other factors playing a role? Join host Dr. Jay Goldstein as he welcomes D...

Host: Mark DeLegge, MD Guest: Andrew Chan, MD, MPH Guest: David Lieberman, MD It's currently recommended that patients at average risk for colorectal cancer repeat a colonoscopy every 10 years. Is the 10-year interval appropriate for average-risk patients, or would patients benefit from more frequent colonoscopies? What evidence do we have to support the idea that more frequent colonoscopies would...

Host: Mark DeLegge, MD Guest: T. Karl Byrne, MD What are the advantages to each of the two main types of obesity surgeries— gastric bypass and lap band surgery? How do the recovery times, efficacy and potential complications compare? Host Dr. Mark DeLegge welcomes Dr. T. Karl Byrne, professor of surgery and medical director of the Bariatric Surgery Center at the Medical University of South Carolin...

Host: Mark DeLegge, MD Guest: Douglas Rex, MD Fecal immunochemical testing (or FIT testing) replaces the older stool guaiac test in the recent colorectal cancer screening guidelines. What's the advantage to FIT testing? Is there a place for fecal DNA testing in the realm of colorectal cancer screening methods right now, or does this procedure need further revision? Host Dr. Mark DeLegge discusses...

Host: Mark DeLegge, MD Guest: Lisa Boardman, MD Early detection through screening for colorectal cancer (CRC) can make a huge impact in preventing the development or progression of CRC. What screening methods are most recommended? Dr. Lisa Boardman, assistant professor of medicine at the Mayo Clinic, reviews details of the CRC screening guidelines from both the Joint Effort Panel, as well as the U...

Host: Jay Goldstein, MD Guest: Robert Bresalier, MD What are some common gastrointestinal complications from oncologic therapies? How can physicians differentiate a side effect from a condition that requires further evaluation? Host Dr. Jay Goldstein welcomes Dr. Robert Bresalier, professor of medicine in the department of gastrointestinal medicine and nutrition at the M.D. Anderson Cancer Center,...

Host: Jay Goldstein, MD Guest: J. Randolph Hecht, MD How have treatments for colorectal and pancreatic cancers advanced in recent years, and are novel treatments reducing the mortality rate of patients with these cancers? Dr. J. Randolph Hecht, director of the GI Oncology Program at the UCLA Health System and clinical professor of medicine in the hematology-oncology division at the UCLA David Geff...